Mesenchymal stromal cells (MSCs) possess profound immunomodulatory and regenerative
properties that are of clinical use in numerous clinical indications with unmet medical need …

Graft versus host disease (GvHD) is the clinical condition in which bone marrow-derived
mesenchymal stromal cells (MSCs) have been most frequently studied. In this review, we …

Background Graft-versus-host disease (GVHD) is a common fatal complication of
hematopoietic stem cell transplantation (HSCT), where steroids are used as a treatment …

The outbreak of 2019 novel coronavirus disease (COVID-19) worldwide is becoming rapidly
a major concern. The number of severe cases has increased dramatically worldwide, while …

The therapeutic potential of mesenchymal stem cells (MSCs) has been investigated in many
preclinical and clinical studies. This potential is dominantly based on the …

Since its eruption in China, novel coronavirus disease (COVID‐19) has been reported in
most of the countries and territories (> 200) of the world with∼ 18 million confirmed cases …

Graft versus host disease (GVHD) is a severe complication after allogenic hematopoietic cell
transplantation (HSCT). Several clinical trials have reported the use of mesenchymal stromal …

Objective Steroids-refractory (SR) acute graft-versus-host disease (aGVHD) is a life-
threatening condition in patients undergoing allogeneic hematopoietic stem cell …

Herein we review current practice regarding the management of chronic graft-vs.-host
disease (cGvHD) in paediatric patients after allogeneic haematopoietic stem cell …

Mesenchymal Stromal Cells (MSCs) are fibroblast-like cells of mesodermal origin present in
many tissues and which have the potential to differentiate to osteoblasts, adipocytes and …